Non-Interventional Post Marketing Surveillance Study To Observe The Safety And Efficacy Of Vfend® Tablet In Korea

Pfizer

Status: Completed

Conditions: Serious Fungal Infections

Treatments: Drug: voriconazole tablet

Study type: Observational

Funder types: Industry

Identifiers

NCT01073631

A1501068

Details and patient eligibility

About

This is a non-interventional study of voriconazole tablet in Korea which is mandated by the Korean government agency.

Enrollment: 543 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who are indicated for voriconazole table according to the drug package insert.

Exclusion criteria

• None.

Trial design

543 participants in 1 patient group

1

Description:

Patients who are indicated for use of voriconazole tablet.

Treatment:

Drug: voriconazole tablet